Innovation Access Fund: Zero Shares Tendered, NAV $17.25

Who runs it and who can buy it

The filings are specific. Innovation Access Fund “was organized as a Delaware statutory trust on January 18, 2022” and “commenced operations on January 29, 2026”. SilverBay Capital Management LLC is the investment adviser, and “the Adviser is controlled by its sole member, Alkeon Capital Management, LLC”. Alkeon is also the non-managing member of Breakwater Group Distribution Services, LLC, the broker-dealer that distributes the shares. The same adviser group runs ACAP Strategic Fund (XCAPX), an equity long/short interval fund; this fund is a different product with a different job.

The objective is “to achieve maximum capital appreciation”. The fund puts at least 80% of its assets in private and public “Innovation Companies” (technology or technology-affected companies) and “generally targets an approximate 50/50 allocation (other than cash and cash-related instruments)” between a private sleeve and a publicly traded sleeve, with about 10% in cash or cash-related instruments. It may sell short, borrow and use total return swaps or options.

It is not a retail product in the usual sense. Buyers must have “a net worth of more than $2,200,000” excluding the primary residence, or otherwise be a “qualified client”, and be an accredited investor. Class A and Class W need $50,000 to start (later purchases at least $5,000), Class I needs $10,000,000. Shares are bought monthly through an adviser or broker, and tenders go “through your financial advisor”: the offer documents say the letter of transmittal “must be returned to your financial advisor only”. The two tests are explained in qualified purchaser vs accredited investor.

Four offers in seven months

Accession numbers: 0001206774-26-000179 and -000271 (offer 1), -000258 and -000291 (offer 2), -000362 and -000552 (Q3), -000579 (Q4). The first two were “special tender offers”; the fund's own policy, written in the semiannual report, is that “commencing with the first full calendar quarter following the first investment in the Fund by investors that are not the Adviser or its affiliates”, the Adviser “intends to recommend to the Fund's Board that the Fund make quarterly offers to repurchase its Shares in an amount equal up to the value of 4%”. The semiannual report puts that first outside investment on May 1, 2026, so the first full calendar quarter after it is the third quarter of 2026 and the July 27 offer is the first regular quarterly one (our reading). The same note adds: “There can be no assurance that the Fund will make such repurchase offers.”

How the second special offer ended is the most revealing paragraph in the file. On May 21, 2026 the fund terminated it, and the Board “considered relevant factors, including an indication from the Fund’s sole shareholder (when the Offer commenced) that it does not intend to withdraw capital from the Fund at this time, thereby removing the anticipated need for liquidity that the Offer was intended to address”. The Board also considered that continuing could “give rise to unnecessary or misleading signals to the marketplace, including a potential misperception of a likely reduction in the Fund’s assets under management”.

Why zero were tendered, and what that does not show

The filings do not say why nobody tendered in August 2026. They do show conditions that make a tender unlikely this early (our reading, not a statement from the fund):

• No outside holder had been in the fund for four months. The first outside investment was May 1, 2026 and the Q3 offer expired August 26, 2026.
• A 2% fee applies to any share held under a year. The Q3 and Q4 offer documents both say a shareholder tendering “prior to holding such Shares for at least one year” pays an early repurchase fee equal to 2% of the amount purchased. The fund began on January 29, 2026, so on the December 31, 2026 pricing date no share has been held a full year (our arithmetic). The fee “may be waived by the Fund in circumstances where the Board determines that doing so is in the best interests of the Fund”.
• A large part of the share count belongs to an affiliate of the adviser. The Q3 offer states that the controlling person and Chief Investment Officer “beneficially owned 4,904,795 Class W Shares” and “3,927,824 Class I Shares”, held of record “by an affiliate of the Adviser”; the Q4 offer repeats the same share counts at September 30, 2026.

The filing's own percentages sum to 69.67% and 48.58%, a little above our share ratios; the filing does not give its denominator. Valued at the September 30, 2026 NAVs, the affiliate's 4,904,795 Class W shares ($18.12) and 3,927,824 Class I shares ($17.25) are about $156.6 million, 48.6% of the $322.5 million fund (our arithmetic). The other officers named in the filing own no shares. The rest, 8,758,899 Class A shares and 851,227 Class I shares (Class I outstanding of 4,779,051 less the affiliate's 3,927,824, our arithmetic), is roughly $165.8 million at September 30 prices, and the 4% cap of $12.9 million equals 7.8% of that (our arithmetic). That is the pool that could tender without the affiliate: a fund at this stage has not yet been tested.

NAV: from $10.00 to $18.12 on Class W in eight months

Class W began at $10.00 a share ($50,000,000 for 5,000,000 shares, all owned by an affiliate of the adviser at March 31). From March 31 to June 30, 2026 Class W NAV rose from $9.70 to $16.61 (+71.2%) and in the third quarter from $16.61 to $18.12 (+9.1%), against +9.0% for Class A ($15.82 to $17.25) (all our arithmetic). Per-share NAVs of the three classes are not comparable: Class W has stayed about 5.0% above Class A and Class I at both dates (1.0499 and 1.0504, our arithmetic), a gap the reports do not explain. Those are NAV changes per share, not what any holder earned, since investors came in at different dates and prices.

What drove the second-quarter jump is visible in the N-PORT filings. At March 31, 2026 the fund held 48,236 Anthropic PBC Series G-1 preferred shares valued at $12,517,242, 25.82% of net assets, acquired on January 29, 2026 at a cost of $12,499,703, a position the report says “is valued using significant unobservable inputs”. At June 30, 2026 the same 48,236 shares are carried at $28,411,486.36, and a second Anthropic line of 67,532 voting common shares is carried at $39,777,023.32. Our arithmetic: that is $259.50 a share at March 31 and $589.01 at June 30 (+127%). The September 30 holdings are not public yet, so what produced the 9% in the third quarter cannot be read from filings.

What it held at June 30, 2026

Net assets were $206,113,189.06, total assets $218,199,466.68 and liabilities $12,086,277.62. Percentages add to about 105.9% because total assets exceed net assets by the $12.1 million of liabilities (our arithmetic). The two Anthropic lines together are $68,188,509.68, 33.08% of net assets, and the 11 lines the N-PORT titles “Private Equity” total $73.4 million, 35.6% (our sums). The fund's stated target is about half in the private sleeve, so a holdings list taken three months later will look different. The filing describes the fund as non-diversified, and the N-PORT shows 39 lines.

What it costs

For the first two months the fund ran expenses of $177,697 (professional fees $78,501, administration $25,799, trustees $19,209, Class W servicing $21,183 and others), and the adviser waived or reimbursed all of it, so net expenses were zero.

A worked example (our arithmetic) on $100,000 in Class A: 0.85% is $850 a year, and once the waiver ends 1.25% is $1,250, together $2,100 a year before any incentive fee and fund expenses. If the fund earned $10,000 on that stake in a year with no loss carryforward, 15% would be $1,500 (a simplification of the formula, which is applied to the fund's net profits). Tendering the whole $100,000 before the first anniversary costs 2%, $2,000. On the fund's $322.5 million at September 30, 1.25% is about $4.0 million a year, so the waiver is worth that much to the fund until about May 2027.

The December 2024 draft registration statement had different terms: a 1.50% management fee, a 5.00% early repurchase fee for two years and a 2.50% maximum Class A sales load, with many fields still blank. The 2026 reports are the ones that govern.

How the open offer works, and the dates

The cover letter says the fund “is offering to purchase up to 4% of the Fund’s shares of beneficial interests” outstanding at September 30, 2026, “at a price equal to the net asset value of such Shares as of December 31, 2026”. The shareholder instructs the financial advisor, who must receive the letter of transmittal by 12:00 midnight Eastern Time at the end of November 25, 2026, so earlier in practice. Tenders can be withdrawn until December 7, 2026; if the fund has not accepted a tender by December 24, 2026 the shareholder can withdraw after that date. Payment is due “within seven (7) days of the Valuation Date”, in cash from “cash on hand, proceeds from the sale of portfolio holdings or borrowings”. The shareholder bears the price risk for three months: the offer states the NAV “likely will change” between September 30 and December 31, 2026.

If more than 4% is tendered, the fund may accept up to the extra amount allowed by Rule 13e-4(f)(1)(ii), extend and increase the offer, or accept tenders pro rata. The offer is “not conditioned on any minimum number of Shares being tendered”, and it may be cancelled, amended or postponed, for example if there is a “material decrease in the net asset value of the Fund”. A tender is a taxable sale in a taxable account; the offer document gives the general rules and tells holders to consult their own advisers.

What a reader can do with this

• If you hold shares: the useful numbers are the pricing date (December 31, 2026, not September 30), the 2% fee if you are inside your first year, and whether your adviser has waived it in writing. Ask the adviser to confirm the deadline for requests, which is earlier than the fund's.
• If you are considering a purchase: ask for the offering memorandum and the sales load in writing, ask who holds the other shares, and note that the quarterly repurchase is a 4% intention that the Board can drop. The record so far is three offers with no shares tendered.
• If you are comparing: the interval fund structure must repurchase at least 5% a quarter; a tender-offer fund like this one does not, and in other young funds we have read the same pattern of empty windows, for example Eagle Point Trinity Senior Secured Lending. For how these Schedule TO filings are counted across funds, see the tender offer funds census.
• What would change the picture: the first offer with outside holders past a year, a tender above 4%, the audited annual report for the year to September 30, 2026, and the next holdings list.

FAQ

All figures are from SEC filings of Innovation Access Fund (CIK 1905379) read on EDGAR on October 29, 2026: Schedules TO and amendments of April 1, April 30, May 5, May 21, July 27, October 2 and October 27, 2026 and the Offer to Purchase exhibits to the last two (accessions 0001206774-26-000179, -000258, -000271, -000291, -000362, -000552 and -000579); the semiannual report on Form N-CSRS for the period to March 31, 2026 (0001206774-26-000314); Form N-PORT filings for March 31 and June 30, 2026 (0001193125-26-239358 and 0001193125-26-374492); and the December 2024 draft registration statement on Form N-2/A (0001206774-24-001204). Percentages, sums and implied values are our arithmetic. This is analysis of public documents, not investment, legal or tax advice.